glp 1 plotter GLP1 Dose Calculator glp 1 receptor concentration estimate

The 2% of adults now taking GLP-1s specifically for an overweight or obesity diagnosis represents a 587% increase over the last five years

A large retrospective study presented at the European Academy of Dermatology and Venereology found that GLP-1 use was independently associated with increased incidence of telogen effluvium (TE), androgenic alopecia (AGA), and nonscarring hair loss in general

Integrating behavioral counseling and psychological monitoring for instance through motivational interviewing, cognitive-behavioral strategies, or digital adherence tools could enhance both pharmacologic and lifestyle outcomes

What we do have are case reports of atypical moles showing up soon after use, plus warnings from cancer groups and regulators against tanning injections and sprays

Thyroid dysfunction and kidney disease: an update